SynthesisMedicine2020

Efficacy and safety of erlotinib combined with bevacizumab in the treatment of non-small cell lung cancer: A systematic review and meta-analysis.

Kenan Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.